Salmon, Marsha v. Octapharma Plasma

2025 TN WC 11
CourtTennessee Court of Workers' Compensation Claims
DecidedMarch 4, 2025
Docket2023-06-7650
StatusPublished

This text of 2025 TN WC 11 (Salmon, Marsha v. Octapharma Plasma) is published on Counsel Stack Legal Research, covering Tennessee Court of Workers' Compensation Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Salmon, Marsha v. Octapharma Plasma, 2025 TN WC 11 (Tenn. Super. Ct. 2025).

Opinion

FILED Mar 04, 2025 10:33 AM(CT) TENNESSEE COURT OF WORKERS' COMPENSATION CLAIMS

TENNESSEE BUREAU OF WORKERS’ COMPENSATION IN THE COURT OF WORKERS’ COMPENSATION CLAIMS AT NASHVILLE

Marsha Salmon, ) Docket No. 2023-06-7650 Employee, ) v. ) Octapharma Plasma, ) State File No. 69577-2020 Employer, ) And ) Sentry Insurance, ) Judge Kenneth Switzer Carrier. ) )

COMPENSATION ORDER GRANTING MOTION TO DISMISS WITH PREJUDICE ________________________________________________________________________

The Court held a hearing on Octapharma Plasma’s motion to dismiss on March 3, 2025. Octapharma argues that Marsha Salmon has not complied with court orders, failed to prosecute her claim, and did not oppose its motion in writing. Ms. Salmon counters that she is actively marshaling her medical proof. For the reasons below, the Court dismisses her claim.

Procedural History

Ms. Salmon, through counsel, filed a petition in October 2023 alleging injuries to her back, a broken foot, and tendon damage suffered on September 3, 2020. Among the requested relief was return visits to the authorized physicians Dr. Robert Lowe and James Yu for the assignment of impairment ratings. 1

1 The file also contains a dispute resolution statement and accompanying documents totaling over 600 pages. The Court did not read or consider this filing as part of the claim history. A dispute resolution statement “is an internal form issued by a mediator to summarize the terms of any agreement reached by the parties as to one or more preliminary issues in the case[.]” Thomas v. Duracell-Cleveland, 2024 TN Wrk. Comp. App. Bd. LEXIS 11, at *8 (Mar. 11, 2024).

1 In April 2024, Ms. Salmon’s attorney filed a motion to withdraw. He asserted that a settlement had been reached but he was unable to communicate with her and had notified her of his intent to withdraw. Not long afterward at a status hearing, the Court set a hearing date for her attorney’s motion and ordered Ms. Salmon to appear at that hearing, which she did. At that May hearing, Ms. Salmon and her counsel agreed to confer afterward to discuss the proposed settlement.

At the next hearing in July, counsel renewed his motion to withdraw, which the Court granted. The order instructed Ms. Salmon on procedures for receiving assistance from an attorney advisor with the Bureau of Workers’ Compensation and reset the status hearing approximately one month later. Ms. Salmon did not appear at that hearing, so the Court reset it to September. At that hearing, Octapharma informed the Court that Ms. Salmon was assigned a 4% rating for her foot. Ms. Salmon contested that rating, said she injured her back as well in the accident, and she now suffers neuropathy in both feet from the incident. The Court ordered the parties to return to mediation and set another hearing.

At the October scheduling hearing, the parties said that a dispute certification notice would be issued shortly. Octapharma’s attorney reminded that authorized physician Dr. Yu gave a 4% impairment rating for her work-related foot injury, and Dr. Lowe gave a 0% rating on the back. Ms. Salmon repeated her disagreement with the ratings, so the Court explained that she would need medical proof to contest the authorized physicians’ conclusions. Ms. Salmon said she was seeking opinions from an orthopedist and a foot specialist, so the Court set a January 15, 2025 deadline for her to file a notice with the Court Clerk identifying her medical experts. Octapharma’s counsel also said she planned to send written discovery that same day, and the Court told Ms. Salmon that she must respond within 30 days of receipt.

In early January 2025, Octapharma filed this motion to dismiss, asserting that it had not received responses to its written discovery. This was despite counsel notifying Ms. Salmon when her responses were overdue and the previous Court order. Octapharma’s grounds were two-fold: failure to comply with an order and to prosecute. Ms. Salmon did not file a response to that motion. Later that same month at a status hearing, Octapharma stated another ground to support its motion to dismiss: Ms. Salmon had not disclosed her experts in compliance with the January 15 deadline under the scheduling order.

At that same hearing, Ms. Salmon said she received the last order but denied that she received any communication from Octapharma’s counsel. The Court verified Ms. Salmon’s contact information including her email address during the hearing. Octapharma’s attorney also sent Ms. Salmon an email during the hearing, which she received.

2 The Court ordered Octapharma to immediately resend all written discovery, and that Ms. Salmon must respond within 30 days. The Court also ordered Octapharma’s counsel to refile its motion to include a hearing date and time as required by Bureau rules, which she did that same day. The order also stated: “Ms. Salmon is cautioned that she must respond to all written discovery. She must have her experts identified and secure their written opinions by the next hearing, providing copies of medical records and reports immediately upon receipt to Octapharma’s counsel.” The order further advised:

Ms. Salmon is cautioned that she must file a response, or the motion will be unopposed and likely granted. Ms. Salmon may consult with an ombudsman by calling (800) 332-2667. She is encouraged to complete a certificate of nonrepresentation so she may receive limited legal advice from an attorney advisor.

At the hearing, Octapharma listed three grounds for dismissal. Ms Salmon has failed: 1) to respond to the motion to dismiss; 2) to respond to written discovery, contrary to a court order; and 3) to identify her medical experts, despite a court order.

In response, Ms. Salmon said she has seen Dr. Tod Bushman for her foot and Dr. Steven Abram for her back, both of whom have ordered multiple diagnostic tests, some of which have not been completed yet. She wants to “get everything together and go from there.” Ms. Salmon argued she cannot control the pace with which the doctors form their opinions, which she has been diligently pursuing. She remains disabled and cannot work, she said.

Octapharma replied by reminding of the 2020 injury date and that Ms. Salmon has known since she disavowed the proposed settlement that she needs additional proof. Moreover, Ms. Salmon gave no explanation for her failures to respond to discovery or to identify her experts.

Law and Analysis

Tennessee Rule of Civil Procedure 41.02(1) (2024) provides that a case may be dismissed “[f]or failure . . . to prosecute or to comply with these rules or any order of court.” Rule 41.02(3) further states that dismissal under this rule is “with prejudice, thereby operating as an adjudication of the claim on its merits.” Lightfoot v. Xerox Bus. Sys’s, 2026 TN Wrk. Comp. App. Bd. LEXIS 43, at *19 (Sept. 12, 2016).

The Appeals Board in Lightfoot wrote that this type of dismissal is disfavored and a “drastic sanction.” Id. The Board wrote, “In determining whether a case should be dismissed for failure to prosecute, the trial judge may inspect the entire procedural history of the case before deciding whether to dismiss it for want of prosecution. Each case, of

3 course, must be evaluated within its own procedural context.” Id. at *19-20. In affirming the trial court’s decision to involuntarily dismiss a case, the Board reasoned that the employee repeatedly disregarded the court’s instructions “to move the case forward by taking specific actions by a specific date and [the Court] made clear that the case would be dismissed with prejudice if [the employee] failed to heed the court’s orders.” Id. at *18. The Board wrote, “It is fundamental that a trial court has the discretion to control litigation before it through the use of case supervision and docket management.” Id. at *17.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

§ 50-6-239
Tennessee § 50-6-239(d)(3)

Cite This Page — Counsel Stack

Bluebook (online)
2025 TN WC 11, Counsel Stack Legal Research, https://law.counselstack.com/opinion/salmon-marsha-v-octapharma-plasma-tennworkcompcl-2025.